166 related articles for article (PubMed ID: 12079511)
21. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.
Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE
Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433
[TBL] [Abstract][Full Text] [Related]
22. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis.
Hishida M; Nomoto S; Inokawa Y; Hayashi M; Kanda M; Okamura Y; Nishikawa Y; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Takeda S; Kodera Y
Int J Oncol; 2013 Jul; 43(1):88-94. PubMed ID: 23695389
[TBL] [Abstract][Full Text] [Related]
24. Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma.
Chen ZM; Crone KG; Watson MA; Pfeifer JD; Wang HL
Am J Surg Pathol; 2005 Dec; 29(12):1600-8. PubMed ID: 16327432
[TBL] [Abstract][Full Text] [Related]
25. Expression profiling in hepatocellular carcinoma with intrahepatic metastasis: identification of high-mobility group I(Y) protein as a molecular marker of hepatocellular carcinoma metastasis.
Chuma M; Saeki N; Yamamoto Y; Ohta T; Asaka M; Hirohashi S; Sakamoto M
Keio J Med; 2004 Jun; 53(2):90-7. PubMed ID: 15247513
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
27. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
[TBL] [Abstract][Full Text] [Related]
28. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
30. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process.
Suzuki T; Yano H; Nakashima Y; Nakashima O; Kojiro M
J Gastroenterol Hepatol; 2002 Sep; 17(9):994-1000. PubMed ID: 12167121
[TBL] [Abstract][Full Text] [Related]
31. Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma.
Yang LY; Wang W; Peng JX; Yang JQ; Huang GW
World J Gastroenterol; 2004 Dec; 10(24):3569-73. PubMed ID: 15534908
[TBL] [Abstract][Full Text] [Related]
32. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
33. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
34. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiles of hepatoma cell line HLE.
Liu LX; Liu ZH; Jiang HC; Zhang WH; Qi SY; Hu J; Wang XQ; Wu M
World J Gastroenterol; 2003 Apr; 9(4):683-7. PubMed ID: 12679910
[TBL] [Abstract][Full Text] [Related]
36. Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.
Sun H; Tang H; Xie D; Jia Z; Ma Z; Wei D; Mishra L; Gao Y; Zheng S; Xie K; Peng Z
Clin Cancer Res; 2016 Jan; 22(2):502-12. PubMed ID: 26338995
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
38. The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma.
Harimoto N; Taguchi K; Shirabe K; Adachi E; Sakaguchi Y; Toh Y; Okamura T; Kayashima H; Taketomi A; Maehara Y
Oncology; 2010; 78(5-6):361-8. PubMed ID: 20798558
[TBL] [Abstract][Full Text] [Related]
39. Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma.
Yamamoto Y; Sakamoto M; Fujii G; Kanetaka K; Asaka M; Hirohashi S
Clin Cancer Res; 2001 Feb; 7(2):297-303. PubMed ID: 11234883
[TBL] [Abstract][Full Text] [Related]
40. Talin-1 interaction network promotes hepatocellular carcinoma progression.
Chen P; Zheng X; Zhou Y; Xu Y; Zhu L; Qian Y
Oncotarget; 2017 Feb; 8(8):13003-13014. PubMed ID: 28099903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]